BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cell News » Press Releases » Page 10

Gameto Secures $44M Series C to Advance Fertilo as First iPSC-Derived Reproductive Therapy to Reach Phase 3 in the U.S.

By Leave a Comment

  • As birth rates decline and US IVF access falls further behind, Gameto recruits first Phase 3 patients for cutting-edge biotechnology to reignite reproductive health possibilities
  • Company’s $127 million in total funding represents one of the largest investment in reproductive US biopharma sector to date

AUSTIN, Texas, Aug. 12, 2025 – Gameto, a clinical-stage biotechnology company developing stem cell-derived therapies for reproductive health, today announced the completion of a $44 million Series C financing round led by Overwater Ventures, with participation from Insight Partners, RA Capital, Two Sigma Ventures, BOLD Capital Partners, Future Ventures, Ingeborg Investments, Arcadia Investment Partners, PAGS Group, Pontiva Healthcare Partners, Portfolia, and additional investors. [Read more…]

Mirugen Secures A$4.5M to Advance In Vivo Cell (Re)programming, Positioning Itself as a Pioneer in the Field

By Leave a Comment

Mirugen has built a strong syndicate of Australia’s leading life science and deep tech investors to drive its next phase of growth, appointing seasoned biotech entrepreneur Charlotte Casebourne Stock as Executive Chair and Acting CEO to guide the company through key development milestones.

[Read more…]

TriHaz Solutions Opens New Nashville, Tennessee Facility to Expand Regulated Medical Waste Services Across Tennessee

By Leave a Comment

Nashville, TN – July 16, 2025 – TriHaz Solutions, a trusted provider of regulated medical waste management, is proud to announce the opening of a new operational facility in Nashville, Tennesee. This expansion strengthens TriHaz’s ability to serve healthcare facilities, laboratories, and clinical operations throughout Tennessee with reliable and fully compliant medical waste disposal services. [Read more…]

Incucyte® CX3 System transforms continuous analysis of 3D cell models with confocal imaging and unmatched throughput

By Leave a Comment

  • New confocal fluorescence imaging minimizes photobleaching and phototoxicity effects, capturing clear images of live 3D culture
  • Industry-leading throughput enables real-time analysis of up to six microplates in parallel, maximizing data generation
  • Comprehensive, intuitive workflows with integrated data analysis empower every scientist to generate high-quality data from complex assays with greater speed and confidence

[Read more…]

Longeveron® Announces Licensing of New Cardiac Selective iPSC Technology for Cardiovascular Disease

By Leave a Comment

  • Longeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of Miami
  • New patent protects a method to derive GHRH-Receptor+ cardiomyogenic cells from pluripotent stem cells (PSCs)
  • New technology substantially advances Longeveron’s repertoire of stem cell therapy technologies
  • Opportunity to expand pipeline in cardiovascular, rare and pediatric disease areas

[Read more…]

Shopping cart0
There are no products in the cart!
Continue shopping
0